Correction: Diabetes management.

Cleveland Clinic journal of medicine(2019)

引用 0|浏览12
暂无评分
摘要
Information was omitted from Table 1 on page 596 of the article, Makin V, Lansang MC. Diabetes management: beyond hemoglobin A (Cleve Clin J Med 2019; 86[9]:595-600, doi:10.3949/ccjm.86a.18031). The sodium-glucose cotransporter 2 (SGLT2) inhibitors pose a low risk of hypoglyemia, and that should have been noted in the table. The corrected table appears online.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要